A Diabetes (Type 1 & 2) programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €18,000–€35,000 in the United States. About 11.5h from New York, inside the EU, visa-free.
If you are researching Diabetes (Type 1 & 2) treatment from the United States, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €18,000–€35,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
MSC protocols aim to modulate the autoimmune attack in type-1 diabetes and improve insulin sensitivity and beta-cell environment in type-2, as an adjunct to medical management. It is delivered under a physician-led protocol and designed to complement your existing care.
| United States (home) | Stem Plus · EU | |
|---|---|---|
| Diabetes (Type 1 & 2) treatment | €18,000–€35,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 11.5h from New York | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.
Kostenlose ärztliche Prüfung